iRadimed Corporation (IRMD) — 分析摘要
iRadimed Corporation(IRMD)的市值为1.25十亿美元,最近一年的营收同比增长了+14.4%。净利润率为26.8%。当前市盈率为52.9倍。
核心要点
- 营收同比变化+14.4%
- 净利润率26.8%
- 市盈率52.9倍
与SURGICAL & MEDICAL INSTRUMENTS & APPARATUS板块的其他公司相比,IRMD的营收增长为+14.4%,市盈率为52.9倍。
iRadimed Corporation (IRMD)
更新 — ET · 来源 POLYGON
红旗与风险提示无重大红旗
基于最新财报,没有触发重大的信用、利润率或趋势红旗。
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
行业
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
员工人数
166
总部
ORLANDO, FL
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
年度每股股息
$0.80
股息收益率
0.87%
股息历史
免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。